event-trade登录编辑
Seoul Economic Daily EnglishCodex · 实盘不做把握 4/10
北京时间·🕒 发布 15:00:05时区推断·⟳ 抓取 15:23:38·⚡ 决策 07-18 15:33:06 +9m28s·101.1 天前

韩国入境游客药房消费高增,药企把药房作为美妆分销渠道

药房消费同比高增和医疗旅游扩张是行业背景,报道没有给出单家公司新增订单、收入指引或独家渠道合同。

📄 原文Seoul Economic Daily English↗ 原文
Foreign Shoppers Flock to Korean Pharmacies, Now Premium Derma Channel
As inbound foreign tourists' shopping routes expand beyond Olive Young and duty-free shops to pharmacies, pharmaceutica…
不做 东国制药(086450.KQ)
不做:行业消费统计和既有渠道扩张叙事,未披露东国制药新增销售额、订单或指引,短线edge不足。
不做 大熊制药(069620.KS)
不做:新品与药房渠道方向偏利好,但没有可量化收入增量或独占催化。
不做 韩美科学(008930.KS)
不做:只是扩充药房专属品牌产品线,缺少金额、订单或业绩指引。
展开详情(成交明细 / 研究档案 / 原文全文 / 决策记录链)

研究档案

🔎 新鲜度:最早出现 2026-07-18 · 扩散 medium · price-in 风险 medium ↗

消息传播链

  1. 2026-07-18首发Seoul Economic Daily非一手原文 ↗
    报道披露外国游客5月韩国刷卡消费、药房消费同比增速和药企渠道动作,属于行业扩散报道。

关键理由

  • 药房消费同比高增和医疗旅游扩张是行业背景,报道没有给出单家公司新增订单、收入指引或独家渠道合同。
  • 东国制药、Daewoong、韩美科学虽被点名,但均是既有品牌和渠道扩张叙事,缺少可量化的短周期业绩增量。

主要风险

  • 若后续公司披露药房专属品牌销售额或上调指引,需重新按业绩增量评估。

反向证据

  • 做多前查反向 · 来源 web · 日期 2026-04-19 · 影响 weakens
    美妆成为东国制药利润驱动的叙事数月前已有报道,本条更多是行业延续而非新订单。
    检索:Dongkook Pharmaceutical cosmetics sales 31% 2026 already reported pharmacy cosmetics 原文 ↗

原文全文

展开原文 · 4,105 字
As inbound foreign tourists' shopping routes expand beyond Olive Young and duty-free shops to pharmacies, pharmaceutical companies are cultivating pharmacies as a premium dermacosmetic distribution channel. Drugmakers are ramping up a "two-track strategy," growing mass-market brands through Olive Young, Daiso, and online malls while supplying pharmacies with exclusive products that emphasize ingredients and functionality.
Foreign tourists' domestic card spending reached 2.1222 trillion won in May this year, surpassing 2 trillion won for the first time ever, according to an analysis of foreign card spending big data from the Korea Tourism Data Lab conducted by the Korea Tourism Organization and released on the 18th. In particular, the growth rate of pharmacy spending was 206.1% year-on-year, the highest among major spending categories. Skincare and massage followed at 154%, and dermatology at 86%.
The growth of the medical tourism market is also supporting this expansion in pharmacy spending. Foreigners' spending on domestic medical tourism grew tenfold in five years, from 56.2 billion won in 2020 to 561.8 billion won last year. The share of pharmacies in total medical spending transactions also rose from 38.24% in 2021 to 59.11% last year, overtaking dermatology to claim the largest share. This is interpreted as reflecting increased demand for purchasing "aftercare" products at pharmacies, which help soothe skin and restore the skin barrier following dermatological procedures.
In response, pharmaceutical companies are entering the market on the strength of ingredient technology accumulated through drug research and development, along with pharmacy distribution networks. They are broadening consumer contact points through Olive Young, Daiso, and official online malls, while highlighting functionality and expertise at pharmacies.
Dongkook Pharmaceutical this month opened "Pharmacie Beauty Solution," a beauty-product-specialized space, at more than 200 pharmacies nationwide. A key feature is that it places high-functional products from pharmaceutical and dermatology-based brands in one location, including cell care products, regenerative creams, and functional shampoos that relieve hair loss symptoms. After establishing a foothold in the general cosmetics distribution market through "Centellian24," the company launched a separate pharmacy-exclusive functional cosmetics brand, "Madeca Pharmacia," last year, strengthening its pharmacy consultation channel. "Consumer interest in beauty products sold at pharmacies based on ingredients and functionality is rising," a Dongkook Pharmaceutical official said. "We selected high-functional products and set up a separate skincare space inside the pharmacy."
Daewoong Pharmaceutical is also growing its dermacosmetic brand "Easydew" on the strength of "DW-EGF," a human-identical epidermal growth factor it developed independently. It recently released three aftercare products that help restore the damaged skin barrier following dermatological care or cosmetic procedures. The strategy is to target the post-procedure care market forming around hospitals, clinics, and pharmacies through a product line emphasizing skin soothing and regeneration.
Hanmi Science is simultaneously expanding brands targeting the general distribution and pharmacy markets. After launching the derma brand "Adesse" this year to target general consumer distribution channels such as Olive Young, it expanded the product line of "Procam," a pharmacy-exclusive derma brand, this month. The move aims to secure both mass appeal and expertise by differentiating brand and product composition by sales channel.
As the pharmacy cosmetics market grows rapidly, moves to systematize related research and pharmacist education are also emerging. The preparatory committee for the establishment of the Korean Society of Pharmacy Cosmetics recently held an inaugural meeting and began full-scale activities. The society plans to pursue research on pharmacy cosmetics ingredients, expert education for pharmacists, and the hosting of academic conferences.

决策记录链 · 只追加

每次领取产生一条记录,重新决策追加一条并以 supersedes 指向被替代的记录(ADR 0014)。

这条决策早于决策账本(2026-10-08 起逐条追加),没有追加记录。